PharmaShots | Incisive News in 3 Shots

Subscribe Now

Treatment

Janssen and BMS Present Results of Milvexian in P-II AXIOMATIC-TKR Study for the Treatment of TKR Surgery at AHA 2021, Published in NEJM

Janssen and BMS Present Results of Milvexian in P-II AXIOMATIC-TKR Study for the Treatment of TKR Surgery at AHA 2021, Published i...

November 16, 2021

GSK and Vir's Sotrovimab Meet its Primary Endpoints in P-III COMET-TAIL Trial for the Treatment of COVID-19

GSK and Vir's Sotrovimab Meet its Primary Endpoints in P-III COMET-TAIL Trial for the Treatment of COVID-19

November 15, 2021

Amgen's Lumykras (sotorasib) Receives CHMP's Positive Opinion for the Treatment of KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer

Amgen's Lumykras (sotorasib) Receives CHMP's Positive Opinion for the Treatment of KRAS G12C-Mutated Advanced Non-Small Cell Lung...

November 15, 2021

Innovent Presented Results of IBI302 in P-Ib Clinical Trial for the Treatment of Neovascular Age-Related Macular Degeneration at AAO 2021

Innovent Presented Results of IBI302 in P-Ib Clinical Trial for the Treatment of Neovascular Age-Related Macular Degeneration at A...

November 15, 2021

PharmaShots Interview: Genmab's Jan van de Winkel Shares Insight on the Tivdak (tisotumab vedotin-tftv) for the Treatment of Recurrent or Metastatic Cervical Cancer

PharmaShots Interview: Genmab's Jan van de Winkel Shares Insight on the Tivdak (tisotumab vedotin-tftv) for the Treatment of Recur...

November 15, 2021

Eisai Presents Results of Lecanemab in P-IIb Study 201 Study for the Treatment of Alzheimer's Disease at CTAD 2021

Eisai Presents Results of Lecanemab in P-IIb Study 201 Study for the Treatment of Alzheimer's Disease at CTAD 2021

November 12, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us